Analyst picks & changes

Biogen Inc.

(BGEN)

Josephthal Lyon & Ross analyst Franklin Berger reiterated a "buy" on BGEN following the announcement that

Read the full 206 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE